Incidence and Outcome of Surgical Procedures After Coronary Bare-Metal and Drug-Eluting Stent Implantation
Authors:
- Hiroki ShiomiHSHiroki Shiomi
- Takeshi MorimotoTMTakeshi Morimoto
- Yutaka FurukawaYFYutaka Furukawa
- Yoshihisa NakagawaYNYoshihisa Nakagawa
- Kazushige KadotaKKKazushige Kadota
- Masashi IwabuchiMIMasashi Iwabuchi
- Satoshi ShizutaSSSatoshi Shizuta
- Tomohisa TadaTTTomohisa Tada
- Junichi TazakiJTJunichi Tazaki
- Yoshihiro KatoYKYoshihiro Kato
- Mamoru HayanoMHMamoru Hayano
- 1 April 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 5 (2) , 237-246
Abstract
Background—: There still remain safety concerns on surgical procedures after coronary drug-eluting stents (DES) implantation, and optimal management of perioperative antiplatelet therapy (APT) has not been yet established. Methods and Results—: During 3-year follow-up of 12 207 patients (DES=6802 patients and bare-metal stent [BMS] only=5405 patients) who underwent coronary stent implantation in the CREDO-Kyoto registry cohort-2, surgical procedures were performed in 2398 patients (DES=1295 patients and BMS=1103 patients). Surgical procedures (early surgery in particular) were more frequently performed in the BMS group than in the DES group (4.4% versus 1.9% at 42-day and 23% versus 21% at 3-year, log-rank P =0.0007). Cumulative incidences of death/myocardial infarction (MI)/stent thrombosis (ST) and bleeding at 30 days after surgery were low, without differences between BMS and DES (3.5% versus 2.9%, P =0.4 and 3.2% versus 2.1%, P =0.2, respectively). The adjusted risks of DES use relative to BMS use for death/MI/ST and bleeding were not significant (hazard ratio: 1.63, 95% confidence interval: 0.93 to 2.87, P =0.09 and hazard ratio: 0.6, 95% confidence interval: 0.34 to 1.06, P =0.08, respectively). The risks of perioperative single- and no-APT relative to dual-APT for both death/MI/ST and bleeding were not significant; single-APT as compared with dual-APT tended to be associated with lower risk for death/MI/ST (hazard ratio: 0.4, 95% confidence interval: 0.13 to 1.01, P =0.053). Conclusions—: Surgical procedures were commonly performed after coronary stent implantation, and the risk of ischemic and bleeding complications in surgical procedures was low. In patients selected to receive DES or BMS, there were no differences in outcomes. Perioperative administration of dual-APT was not associated with lower risk for ischemic events.Keywords
This publication has 15 references indexed in Scilit:
- Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in JapanCardiovascular Intervention and Therapeutics, 2011
- Incidence and outcome of surgical procedures after sirolimus-eluting stent implantation: a report from the j-Cypher registryCardiovascular Intervention and Therapeutics, 2009
- Characterization of Post-Operative Risk Associated With Prior Drug-Eluting Stent UseJACC: Cardiovascular Interventions, 2009
- Discontinuation of antiplatelet therapy prior to low‐risk noncardiac surgery in patients with drug‐eluting stents: A retrospective cohort studyJournal of Hospital Medicine, 2007
- Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery StentsCirculation, 2007
- Noncardiac Surgery After Coronary Stenting: Early Surgery and Interruption of Antiplatelet Therapy Are Associated With an Increase in Major Adverse Cardiac EventsJACC, 2007
- Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapyThe Lancet, 2004
- Major noncardiac surgery following coronary stenting: When is it safe to operate?Catheterization and Cardiovascular Interventions, 2004
- Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stentingJACC, 2003
- Catastrophic outcomes of noncardiac surgery soon after coronary stentingJACC, 2000